Bharat Immunologicals Market Risk Adjusted Performance

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 21.3  0.1  0.47%

The Macroaxis Technical Indicators lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh
Bharat Immunologicals Biologicals Corp Ltd has current Market Risk Adjusted Performance of 3.34.
Bharat Immunologicals 
MRAP 
 = 
ER[a] + (1/BETA - 1) 
ER[a] - RFR) 
 = 
3.34
ER[a] =   Expected return on investing in Bharat Immunologicals
RFR =   Risk Free Rate of return. Typically T-Bill Rate
BETA =   Beta of the asset with market or selected benchmark.

Market Risk Adjusted Performance Comparison

Bharat Immunologicals Biologicals Corp Ltd is rated second in market risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  2.67  of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Bharat Immunologicals Biologicals Corp Ltd is roughly  2.67 
Compare Bharat Immunologicals to competition
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. more
NameBharat Immunologicals Biologicals Corp Ltd
Macroaxis Advice
InstrumentIndia Stock Stocks Directory
ExchangeBombay Stock Exchange
CurrencyINR